The Innovative Medicines Initiative (IMI) has launched its 10th Call for proposals, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.
Based on the recommendations of the IMI Research Agenda the IMI Governing Board has approved the Scientific Priorities 2013 as part of IMI Annual Implementation Plan 2013 . One of these priorities is implemented through the IMI 10th Call Topics (see Information Package below).
The topic for this Call for proposals is: ‘Immunological assay standardisation and development for use in assessments of correlates of protection for influenza vaccines’.
IMI encourages small and medium-sized enterprises (SMEs), patients’ organisations, regulatory authorities, academic teams, industry, hospitals and other organisations to form consortia and apply for participation in the new IMI projects.
For further information visit the IMI-homepage (see link above).
